[Biojava-dev] Subversion

mark.schreiber at group.novartis.com mark.schreiber at group.novartis.com
Sun Sep 26 21:24:08 EDT 2004


While I'm in a ranting mood,

What do people think about moving our CVS base to subversion?? The webDAV 
protocol seems a lot nicer than CVS. Particularly where firewalls are 
involved.

Any thoughts?

- Mark

Mark Schreiber
Principal Scientist (Bioinformatics)

Novartis Institute for Tropical Diseases (NITD)
10 Biopolis Road
#05-01 Chromos
Singapore 138670
www.nitd.novartis.com

phone +65 6722 2973
fax  +65 6722 2910



More information about the biojava-dev mailing list